Radiation plus concurrent nimotuzumab versus CDDP in locally advanced nasopharyngeal cancer: Results of a phase III randomised trial.

被引:7
|
作者
Kong, Lin
Lin, Qin
Hu, Chaosu
Xu, Tingting
Liao, Xiyi
Shen, Chunying
Lu, Jiade J.
机构
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Shanghai Proton & Heavy Ion Ctr, Shanghai, Peoples R China
[3] Xiamen Univ, Affiliated Hosp 1, Xiamen, Fujian, Peoples R China
关键词
D O I
10.1200/JCO.2016.34.15_suppl.6002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6002
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Lung Cancer
    Lebow, E. S.
    Fitzgerald, K. J.
    Shaverdian, N.
    Kotecha, R.
    Gomez, D. R.
    Wu, A. J.
    Gelblum, D.
    Shepherd, A. F.
    Simone, C. B., II
    Zhang, Z.
    Toumbacaris, N.
    Yorke, E. D.
    Eng, J.
    Ng, K.
    Iqbal, A.
    Kris, M. G.
    Rimner, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S57 - S58
  • [32] Prospective Phase 2 Trial of Nimotuzumab and Concurrent Capecitabine and Radiation Therapy for Patients With Locally Advanced Inoperable or Relapsed/ Residual Gastric Cancer: Final Analysis
    Lu, N.
    Jin, J.
    Li, Y.
    Ren, H.
    Fang, H.
    Liu, Y.
    Wang, W.
    Wang, S.
    Song, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S353 - S353
  • [33] COMPLETE RESPONSE (CR) TO NIMOTUZUMAB PLUS CHEMORADIATION IN LOCALLY ADVANCED ESOPHAGEAL CANCER: PRELIMINARY RESULTS OF AN ONGOING RANDOMIZED TRIAL
    Castro, G.
    Segalla, J.
    Stuemoller, C.
    Schmerling, R.
    Andrade, C. J.
    Pinczowski, H.
    Azevedo, S. J.
    Skare, N.
    Silva, C. R.
    Silva, I. D. C. G.
    ANNALS OF ONCOLOGY, 2010, 21 : 260 - 260
  • [34] Radical treatment of locally advanced head and neck cancer with concurrent chemo radiation-cisplatin versus carboplatin: A randomized comparative phase III trial
    Dutta, Shatarupa
    Ghorai, Suman
    Choudhury, Krishnangshu B.
    Majumder, Anup
    CLINICAL CANCER INVESTIGATION JOURNAL, 2013, 2 (02): : 122 - 127
  • [35] Slight advantages of nimotuzumab versus cetuximab plus concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
    Jing, Wang
    Yan, Weiwei
    Liu, Yuguo
    Li, Ji
    Yu, Jinming
    Zhu, Hui
    CANCER BIOLOGY & THERAPY, 2019, 20 (08) : 1121 - 1126
  • [36] Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: longterm results of a phase II study of UFT/CDDP with radiotherapy
    Hiroaki Iwase
    Masaaki Shimada
    Motonori Nakamura
    Keiko Nakarai
    Takasi Iyo
    Syogo Kaida
    Toshihiko Indo
    Eriko Kato
    You Horiuchi
    Kazuo Kusugami
    International Journal of Clinical Oncology, 2003, 8 (5) : 305 - 311
  • [37] A phase I trial of concurrent cetuximab (CET), cisplatin (CDDP), and radiation therapy (RT) women with locally advanced cervical cancer (CXCA): A GOG study
    Moore, K. N.
    Sill, M.
    Miller, D. S.
    Disilvestro, P.
    De Geest, K.
    Rose, P. G.
    Cardenes, H. R.
    Mannel, R. S.
    Farley, J. H.
    Schilder, R. J.
    Fracasso, P. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial
    Huang, Jian-feng
    Zhang, Fu-zheng
    Zou, Qin-zhou
    Zhou, Le-yuan
    Yang, Bo
    Chu, Jian-jun
    Yu, Jia-hua
    Zhang, Hao-wen
    Yuan, Xiao-peng
    Tai, Guo-mei
    Liu, Fen-ju
    Ma, C-M Charlie
    ONCOTARGET, 2017, 8 (02) : 2457 - 2465
  • [39] ACTLACC TRIAL: A PHASE III RANDOMIZED TRIAL COMPARING ADJUVANT CHEMOTHERAPY AFTER CONCURRENT CHEMORADIATION VERSUS CONCURRENT CHEMORADIATION ALONE FOR LOCALLY ADVANCED CERVICAL CANCER
    Tangjitgamol, S.
    Tharavichitkul, E.
    Tovanabutra, C.
    Rongsriyam, K.
    Asakij, T.
    Paengchit, K.
    Sukhaboon, J.
    Penpattanagul, S.
    Kridakara, G. C. A.
    Hanprasertpong, J.
    Chomprasert, K.
    Wanglikitkoon, S.
    Atjimakul, T.
    Pariyawateekul, S. L. P.
    Katanyoo, K.
    Tanprasert, P.
    Janweerachai, W.
    Khunnarong, J.
    Srisomboon, J.
    Lorvidhaya, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 6 - 7
  • [40] Concurrent CBDCA plus radiotherapy for locally advanced head and neck cancer patients inappropriate for use of CDDP
    Hamauchi, Satoshi
    Yokota, Tomoya
    Onozawa, Yusuke
    Ogawa, Hirofumi
    Onoe, Tsuyoshi
    Nishimura, Tetsuo
    Kamijo, Tomoyuki
    Iida, Yoshiyuki
    Onitsuka, Tetsuro
    Yasui, Hirofumi
    ANNALS OF ONCOLOGY, 2015, 26 : 135 - 135